GeminIQ Website Logo

Viewing IRIX free

Subscribe for full history, 90+ metrics, screener, watchlist...

IRIDEX CORP

IRIX

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
556677244578
Accounts Receivable Net Current
678777666776
Inventory Net
10987810111111111010
Prepaid Expense And Other Assets Current
222222222211
Assets Current
242525242729242425282727
Property Plant And Equipment Net
000000000001
Finite Lived Intangible Assets Net
111111111222
Goodwill
111111111111
Operating Lease Right Of Use Asset
001112222233
Other Assets Noncurrent
111111111112
Assets
272829283234293031343435
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
765456768843
Employee Related Liabilities Current
222222222222
Accrued Liabilities Current
111111011121
Convertible Notes Payable Current
--000021--0-
Other Liabilities Current
222222221111
Product Warranty Accrual Classified Current
----------00
Contract With Customer Liability Current
222222222222
Operating Lease Liability Current
001111111111
Liabilities Current
131313121415171616161310
Liabilities Noncurrent
Contract With Customer Liability Noncurrent
667788899101010
Product Warranty Accrual Noncurrent
----------00
Operating Lease Liability Noncurrent
000001111222
Convertible Long Term Notes Payable
44444411--0-
Other Liabilities Noncurrent
000000000000
Liabilities
242424242627272827282523
Preferred Stock Value
------000000
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
929291919190909089898888
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0-0-00000-0-0-0
Retained Earnings Accumulated Deficit
-94-93-92-92-91-90-88-87-85-83-79-76
Stockholders Equity
45556123461012
Preferred Stock Par Or Stated Value Per Share
------0.010.010.010.010.010.01
Liabilities And Stockholders Equity
272829283234293031343435
Allowance For Doubtful Accounts Receivable Current
-----------0
Series B Convertible Preferred Stock
-000000-----
Preferred Stock Shares Issued
------000000
Preferred Stock Shares Outstanding
------000000
Preferred Stock Shares Authorized
----2-222222
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
646464646430643030303030
Common Stock Shares Issued
171717171717171716161616
Shares Outstanding
171717171717171716161616

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20266.67%4.76%-20.95%---------
2025-11.82%-15.45%16.36%7.69%-7.69%-19.23%-1.05%23.16%56.84%8.16%3.06%15.31%
2024-25.32%-32.79%-36.69%7.49%-4.28%-18.72%26.95%25.53%16.31%15.91%14.77%6.82%
2023------27.14%43.81%25.71%---

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.82
1.92
1.91
1.94
1.96
1.95
1.42
1.54
1.55
1.72
2.12
2.64
Quick Ratio
0.89
1.01
1.18
1.22
1.23
1.11
0.65
0.73
0.75
0.91
1.29
1.56
Working Capital
10.79M
11.76M
12.04M
11.67M
13.16M
14.18M
7.00M
8.49M
8.86M
11.51M
14.48M
16.99M
Leverage & Debt
Debt to Equity
6.49
4.98
4.92
5.06
4.21
32.14
12.89
10.50
6.36
4.25
2.62
1.90
Debt Ratio
0.87
0.83
0.83
0.83
0.81
0.80
0.93
0.91
0.86
0.81
0.72
0.65
Efficiency & Turnover
Asset Turnover TTM
1.75
1.68
1.81
1.73
1.58
1.43
1.53
1.49
1.46
1.33
1.35
1.37
Days Sales Outstanding TTM
45.33
46.94
46.99
47.15
49.18
49.38
47.54
45.46
46.58
49.19
45.59
40.99
Receivables Turnover TTM
8.05
7.78
7.77
7.74
7.42
7.39
7.68
8.03
7.84
7.42
8.01
8.90
Per Share Metrics
Diluted EPS TTM
-0.20
-0.19
-0.26
-0.30
-0.32
-0.43
-0.54
-0.67
-0.67
-0.67
-0.59
-0.48
Free Cash Flow Per Share TTM
-0.11
-0.15
-0.13
-0.23
-0.35
-0.41
-0.44
-0.43
-0.36
-0.35
-0.43
-0.47
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
35.92%
35.97%
36.50%
38.18%
39.49%
41.18%
40.07%
38.82%
40.44%
40.72%
42.04%
43.19%
Operating Profit Margin TTM
-5.39%
-5.12%
-4.88%
-6.04%
-7.07%
-10.68%
-17.06%
-22.47%
-21.53%
-21.95%
-19.29%
-15.27%
Net Profit Margin TTM
-6.88%
-6.23%
-8.42%
-10.04%
-10.95%
-14.61%
-18.31%
-22.79%
-21.85%
-21.92%
-18.45%
-14.21%
Growth Metrics
Net Revenue Growth (1Y)
3.68%
7.73%
8.23%
4.58%
0.09%
-2.24%
-6.17%
-11.31%
-11.87%
-12.86%
-8.96%
-4.25%
Net Income Growth (1Y)
-34.88%
-54.08%
-50.20%
-53.91%
-49.83%
-34.83%
-6.90%
42.25%
39.71%
51.04%
26.81%
-12.26%
EPS Growth (1Y)
-37.22%
-55.63%
-51.66%
-55.07%
-51.34%
-36.68%
-8.66%
39.25%
37.56%
48.69%
25.31%
-13.58%
Valuation Metrics
P/E TTM
-5.65
-5.34
-4.35
-3.81
-2.71
-2.32
-3.10
-2.63
-3.24
-4.43
-4.74
-5.31
P/B TTM
5.50
3.69
3.92
4.14
2.44
19.44
13.17
11.06
8.29
7.47
4.76
3.42
P/S TTM
0.39
0.33
0.37
0.38
0.30
0.34
0.57
0.60
0.71
0.97
0.87
0.75
Market Cap
20.03M
17.48M
19.30M
19.39M
14.78M
16.56M
27.62M
29.02M
35.18M
48.43M
45.32M
41.23M
Enterprise Value
19.15M
16.65M
17.01M
17.52M
11.67M
12.96M
27.97M
27.91M
31.07M
43.01M
38.29M
33.25M
Calculated Values
Free Cash Flow TTM
-2.00M
-2.53M
-2.26M
-3.99M
-5.89M
-6.81M
-7.30M
-7.06M
-5.85M
-5.68M
-6.92M
-7.58M
Net Debt
-885.00K
-830.00K
-2.29M
-1.87M
-3.10M
-3.60M
351.00K
-1.10M
-4.11M
-5.42M
-7.03M
-7.98M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-12Purchase
Owner: Dizon, Romeo R
Title: Chief Financial Officer
Shares: 975
Price/Share: $1.14
Value: $1,111.50
Shares Owned: 135,975
Relationship: Officer
Ownership: Direct
2026-06-11Purchase
Owner: Dizon, Romeo R
Title: Chief Financial Officer
Shares: 1,675
Price/Share: $1.14
Value: $1,909.50
Shares Owned: 135,000
Relationship: Officer
Ownership: Direct
2026-06-08Purchase
Owner: Dizon, Romeo R
Title: Chief Financial Officer
Shares: 2,400
Price/Share: $1.12
Value: $2,688.00
Shares Owned: 133,325
Relationship: Officer
Ownership: Direct
2026-06-05Purchase
Owner: Dizon, Romeo R
Title: Chief Financial Officer
Shares: 2,521
Price/Share: $1.15
Value: $2,899.15
Shares Owned: 130,925
Relationship: Officer
Ownership: Direct
2026-06-03Purchase
Owner: Dizon, Romeo R
Title: Chief Financial Officer
Shares: 2,400
Price/Share: $1.17
Value: $2,808.00
Shares Owned: 128,404
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
16.70%
Inst. Shares: 2,891,416
Shares Outstanding: 17,311,000
2025-12-31
16.47%
Inst. Shares: 2,789,652
Shares Outstanding: 16,934,000
2025-09-30
16.66%
Inst. Shares: 2,834,174
Shares Outstanding: 17,009,000
2025-06-30
16.02%
Inst. Shares: 2,689,889
Shares Outstanding: 16,793,000
2025-03-31
18.81%
Inst. Shares: 3,146,650
Shares Outstanding: 16,727,000

IRIDEX CORP (IRIX) — SEC Financial Statements & Analysis

IRIDEX CORP (IRIX) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. IRIDEX CORP trades on Nasdaq as: IRIX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), IRIDEX CORP reported a 3.68% year-over-year revenue growth, a Gross Profit Margin of 35.92% (TTM), a Debt-to-Equity ratio of 6.49x, a Price-to-Sales (P/S) ratio of 0.39x (TTM), a Price-to-Book (P/B) ratio of 5.50x (TTM), at a market cap of $20.03M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
3.68%
Gross Profit Margin TTM
35.92%
Debt To Equity
6.49x
P/S TTM
0.39x
P/B TTM
5.50x
Market Cap
$20.03M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IRIDEX CORP in?

IRIDEX CORP (IRIX) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is IRIX's market cap?

IRIDEX CORP (IRIX) has a market capitalization of $20.03M as of 2026-06-30.

What exchange does IRIX trade on?

IRIDEX CORP (IRIX) trades on the Nasdaq.

Where is IRIDEX CORP incorporated?

IRIDEX CORP is incorporated in DE.

Wall Street's data.
Main Street's price.